
PharmaNest provides high-precision, AI-powered analysis of tissue images to quantify fibrosis and inflammation. It uses single-fiber, high-resolution digital pathology to quantify fibrosis phenotypes from stained slides, with spatial localization and cross-scanner compatibility. The solution is translational and offered as SaaS/services for pharma and research institutions, supporting PSR, MTC, and IHC images. It targets drug development programs across preclinical and clinical studies for various fibrotic conditions, leveraging AI and digital pathology to deliver quantitative insights.

PharmaNest provides high-precision, AI-powered analysis of tissue images to quantify fibrosis and inflammation. It uses single-fiber, high-resolution digital pathology to quantify fibrosis phenotypes from stained slides, with spatial localization and cross-scanner compatibility. The solution is translational and offered as SaaS/services for pharma and research institutions, supporting PSR, MTC, and IHC images. It targets drug development programs across preclinical and clinical studies for various fibrotic conditions, leveraging AI and digital pathology to deliver quantitative insights.